EP Patent

EP1782798A2 — Ascending-dose dosage form

Assigned to Alza Corp · Expires 2007-05-09 · 19y expired

What this patent protects

A dosage form and a method are disclosed for delivering to a human patient a drug in an ascending amount over time. In particular, the invention provides a dosage form having a length greater than its width, the dosage form comprising: (a) a first layer comprising 10 ng to 700 m…

USPTO Abstract

A dosage form and a method are disclosed for delivering to a human patient a drug in an ascending amount over time. In particular, the invention provides a dosage form having a length greater than its width, the dosage form comprising: (a) a first layer comprising 10 ng to 700 mg of a drug selected from methylphenidate or a pharmaceutically acceptable salt thereof; (b) a second layer comprising 80% to 95% of a hydrophilic-expandable polymer; (c) a wall comprising a semipermeable composition that surrounds the first and second layer; (d) an exit in the wall communicating with the first layer for delivering the drug; and wherein the dosage form when in operation administers the drug in an ascending rate over time.

Drugs covered by this patent

Patent Metadata

Patent number
EP1782798A2
Jurisdiction
EP
Classification
Expires
2007-05-09
Drug substance claim
No
Drug product claim
No
Assignee
Alza Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.